- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05890807
Concordance in Diagnosis of Periodontitis in Diabetic Patients Between an Indirect Method Based on a Photograph of the Oral Cavity and a Direct Method Based on the Clinical Examination of This Oral Cavity (Reference). (PARODIABNOSTIC)
Evaluation of the Concordance in the Diagnosis of Periodontitis in Diabetic Patients Between an Indirect Method Based on a Photograph of the Oral Cavity and a Direct Method Based on the Clinical Examination of This Oral Cavity (Reference).
Periodontitis, a known complication of diabetes, is an infectious disease that destroys bone and gums. Studies have shown that diabetes favors periodontitis, and that periodontitis contributes to its aggravation. The positive impact of treating periodontitis on the cost of diabetes care has been demonstrated and the French national health system fully covers the treatment of periodontitis for diabetic patients. Unfortunately, 80% of diabetic patients do not visit their dentist enough.
Although diabetologists regularly see their patients and are aware of the importance of treating periodontitis,they do not have the expertise to diagnose the condition whereas a specialist dentist can often diagnose it just by looking.
This study aims to develop a solution combining the dentist's expertise with that of the diabetologist. This would be based on analysis of a photograph of the patient's oral cavity, taken in the department. So far, no studies have ever evaluated the performance of an expert dentist for diagnosing periodontitis from a simple photograph made by non-dental experts in a diabetic department.
The hypothesis is that the concordance in the diagnosis of periodontitis between an indirect method based on a photograph of the oral cavity and a direct method based on clinical examination of this oral cavity (reference) in the diabetic patient would be satisfactory.
Study Overview
Status
Conditions
Detailed Description
Among the complications of diabetes, periodontitis, an infectious disease that destroys the bone and gums, has a bidirectional relationship with diabetes. Indeed, studies have shown that diabetes favors periodontitis, and that periodontitis contributes to the aggravation of diabetes. In addition, the positive impact of treating periodontitis on the indicators and cost of diabetes management has been demonstrated. To echo these findings, since 2020, the French national health scheme now fully covers the treatment of periodontitis in diabetic patients. Unfortunately, health insurance reports point out that 80% of diabetic patients do not visit their dentist enough.
This makes it difficult to detect and treat periodontitis in diabetic patients at an early stage. At the same time, diabetologists who regularly see their patients confirm the importance of knowing their periodontal condition. But they do not have the expertise to diagnose periodontitis whereas, in most cases, a specialist dentist could diagnose it just by looking. The development of a solution allowing the dentist's expertise to be brought to the service of diabetes may have a positive impact on the management of diabetic patients with periodontitis. This expertise could be based on analyzing a photograph of the patient's oral cavity, taken in the department. So far, no studies have ever evaluated the performance of an expert dentist for diagnosing periodontitis from a simple photograph, made by non-dental experts in a diabetic department.
The hypothesis is that the concordance in the diagnosis of periodontitis between an indirect method based on a photograph of the oral cavity and a direct method based on clinical examination of this oral cavity (reference) in the diabetic patient would be satisfactory.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sophie SCHULDINER, Dr.
- Phone Number: +334 66 68 33 21
- Email: sophie.schuldiner@chu-nimes.fr
Study Contact Backup
- Name: Anissa MEGZARI
- Phone Number: +33466684236
- Email: drc@chu-nimes.fr
Study Locations
-
-
-
Nîmes, France, 30029
- Recruiting
- CHU de Nîmes
-
Contact:
- CHU DE NIMES
- Phone Number: 0466683256
-
Principal Investigator:
- Sophie SCHULDINER
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with type 1 or 2 diabetes.
- Patients of legal age (≥ 18 years).
- Patient undergoing day or weekday hospitalization in the Metabolic and Endocrine Diseases Department at Nîmes University Hospital.
- Patient who has not reported his or her opposition to participating in the study.
- Patient affiliated or beneficiary of a health insurance plan.
Exclusion Criteria:
- Patient who has received treatment for periodontal disease within the past 12 months.
- Patient with fewer (<) than 3 functional contiguous teeth.
- Patient participating in research involving human subjects defined as category 1.
- Patient in an exclusion period as determined by another study.
- Patient under court protection, guardianship, or conservatorship.
- Patient for whom informed information cannot be provided.
- Patient who is pregnant or breastfeeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients whose oral cavity will be photographed in the diabetology department
The patient is seated in the chair.
The trained staff member positions the mouth guard and takes a frontal photograph of the patient's oral cavity using the photo sensor (smart-phone).
Only the oral cavity will be visible in the photograph and there will be no possibility for an external assessor to recognize the patient's face.
|
The diabetologist will take a photograph of the patient's oral cavity in the diabetology department.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parodontitis based on clinical observation of the patient's oral cavity (direct method)
Time Frame: Day 0
|
For the direct method by clinical examination, an expert dentist different from those involved in the indirect method will decide whether YES / NO the patient has parodontitis.
|
Day 0
|
Parodontitis based on a photograph of the patient's oral cavity (indirect method)
Time Frame: Day 0 to day 7
|
For the indirect method, two expert dentists will independently analyze the photographs in order to decide whether YES / NO the patient has parodontitis.
|
Day 0 to day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
A. Sensitivity and specificity of the Positive Predictive Value (PPV) measured by the direct method
Time Frame: Day 0
|
Positive predictive value = True Positive / (True Positives+False Positives)
|
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Hospitalization
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: - the type of hospitalization (day or week) |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Type of diabetes
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: -the type of diabetes (Type I, Type II or other) |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Age of diabetes
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: - Age of diabetes: <1 year, 1-5 years, 5-10 years, 10-20 years, >20 years |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Treatment
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: -treatment: insulin therapy yes/no and the drug used (metformin, hypoglycemic sulfonamides, dipeptidyl peptidase IV inhibitors, SGLT2 inhibitors, GLP1 analogues, other) will be recorded. |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status.HbA1c level
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: - the patient's HbA1c level will be recorded in mmol/mol |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Macrovascular complications
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: -Presence of macrovascular complications will be recorded as YES/NO |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Type of macrovascular complication
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: -The type of macrovascular complication : arteriopathy (cerebral, coronary, lower limbs) will be recorded |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Microvascular complications
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: -presence of microvascular complications, YES/NO |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Type of microvascular complication
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: -The type of microvascular complication (retinopathy, nephropathy, neuropathy) will be recorded |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Smoking
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: - the patient's smoking status (active/number of cigarettes per day/ex-smoker) will be recorded |
Day 0
|
C. Association between the patient's diabetic constants and his/her periodontal status. Periodontitis
Time Frame: Day 0
|
Diabetic findings according to the following criteria recorded for each patient included: Presence of periodontitis (yes/no) according to the reference method, i.e. by odontological examination. |
Day 0
|
A. Sensitivity and specificity of the Positive Predictive Value (NPV) measured by the indirect method
Time Frame: Day 0 to day 7
|
Positive predictive value = True Positive / (True Positives+False Positives)
|
Day 0 to day 7
|
A. Sensitivity and specificity of the Negative Predictive Value (NPV) measured by the indirect method
Time Frame: Day 0 to day 7
|
Negative predictive value = True Negative / (False Negatives + True Negatives)
|
Day 0 to day 7
|
A. Sensitivity and specificity of the Positive Predictive Value (PPV) measured by the indirect method
Time Frame: Day 0 to day 7
|
Negative predictive value = True Negative / (False Negatives+True Negatives)
|
Day 0 to day 7
|
B. Quality of photographs taken by the diabetology department : respect of anonymity
Time Frame: Day 0 to day 7
|
Evaluation of the photograph by two expert dentists who check compliance with the rules established for taking the photo. During the research or at its conclusion, the data collected on the persons who lend themselves to it and transmitted to the sponsor by the investigators (or any other specialized intervening parties) will be made anonymous. Under no circumstances will the names of the persons concerned or their addresses appear in clear text. The patient will be identified only by a unique seven-digit identification number. A list of subject identifications will be kept in the investigator's file. The investigator will ensure that the anonymity of each individual participating in the study is guaranteed. No identifying information will be given to any third party other than those who are authorized by law to hold such information (and who are bound by professional secrecy). |
Day 0 to day 7
|
B. Quality of photographs taken by the diabetology department : visibility of the gums
Time Frame: Day 0 to day 7
|
Two expert dentists will check compliance with the rules established for taking the photo.
For sufficient diagnostic quality, the gums must be clearly visible.
"Periodontal disease" describes all gingivitis and periodontitis.
Gingivitis is characterized by gingival inflammation manifested by redness of the gums, bleeding and localized edema.
The inflammatory process only affects the superficial periodontium (gingival epithelium and gingival connective tissue) and is most often due to an accumulation of bacterial plaque.
However, it can be reversed with specific oral hygiene measures.
When the deep periodontal tissues (alveolar bone, periodontal ligament, cementum) are affected it is called periodontitis.
These lesions are clinically characterized by gingival inflammation and a periodontal pocket (space that is created between the tooth and the gum) as well as by bone loss.
|
Day 0 to day 7
|
B. Quality of photographs taken by the diabetology department : image sharpness
Time Frame: Day 0 to day 7
|
Evaluation of the photograph by two expert dentists who check compliance with the rules established for taking the photo.
Is the image sharpness good enough to clearly visualize the patient's gums?
YES/NO
|
Day 0 to day 7
|
B. Quality of photographs taken by the diabetology department : use of the flash
Time Frame: Day 0 to day 7
|
Evaluation of the photograph by two expert dentists who check compliance with the rules established for taking the photo.
Was the flash used ?
YES/NO
|
Day 0 to day 7
|
B. Quality of photographs taken by the diabetology department : absence of zoom
Time Frame: Day 0 to day 7
|
Evaluation of the photograph by two expert dentists who check compliance with the rules established for taking the photo.Was the zoom used?
YES/NO
|
Day 0 to day 7
|
B. Quality of photographs taken by the diabetology department : orientation
Time Frame: Day 0 to day 7
|
Evaluation of the photograph by two expert dentists who check compliance with the rules established for taking the photo.
Was the photo taken from full front view ?
YES/NO
|
Day 0 to day 7
|
B. Percentage of photographs meeting all of the above criteria for acceptance
Time Frame: Day 0 to day 7
|
The number of photographs that meet all the above acceptance criteria will be converted into a percentage.
|
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Inflammation
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Inflammatory color of the gum The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Root tartar
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Root tartar The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Pus
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Pus The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Bleeding
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Bleeding The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Interdental space
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Interdental space The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Gum retraction
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Retraction of the gum The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Swollen gums
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Gum swelling The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
D. Visible clinical signs associated with periodontitis on the photos taken. Plaque
Time Frame: Day 0 to day 7
|
Evaluation of clinical signs visible on the photos of diabetic patients diagnosed with periodontitis according to the gold standard (odontological examination): -Dental plaque The evaluation will be interpreted by two blinded expert dentists (different from the one who performed the odontological examination) at the end of the inclusion period. Observation of the photographs by two expert dentists. |
Day 0 to day 7
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age of patients
Time Frame: Day 0
|
In years
|
Day 0
|
Height
Time Frame: Day 0
|
In centimeters
|
Day 0
|
Sex of patients
Time Frame: Day 0
|
Male/female
|
Day 0
|
Type of hospitalization
Time Frame: Day 0
|
Inpatients/Outpatients
|
Day 0
|
Periodontal status
Time Frame: Day 0
|
Periodontitis / gingivitis / healthy
|
Day 0
|
Lifestyle
Time Frame: Day 0
|
Lives alone / Lives with family or nearby / Homeless
|
Day 0
|
Level of education
Time Frame: Day 0
|
Primary / Secondary / Graduate / Post-graduate
|
Day 0
|
Professional activity
Time Frame: Day 0
|
Employed / Full-time/ Part-time/ Unemployed
|
Day 0
|
Type of diabetes
Time Frame: Day 0
|
Type 1 / Type 2 / Unknown / Other
|
Day 0
|
Diabetic for how long
Time Frame: Day 0
|
More than 20 years / 10 to 20 years / 5 to 10 years / Less than 5 years / Unknown
|
Day 0
|
Presence of microangiopathic complications
Time Frame: Day 0
|
YES / NO
|
Day 0
|
Presence of retinopathy
Time Frame: Day 0
|
YES / NO / Don't know
|
Day 0
|
Presence of nephropathy
Time Frame: Day 0
|
YES / NO / Don't know
|
Day 0
|
Presence of peripheral neuropathy
Time Frame: Day 0
|
YES / NO / Don't know
|
Day 0
|
Glomerular filtration rate (GFR)
Time Frame: Day 0
|
GFR between 60 and 89 ml/min/1.73
m² GFR between 45 and 59 ml/min/1.73
m² GFR between 30 and 44 ml/min/1.73
m² GFR between 15 and 29 ml/min/1.73
m² GFR < 15 ml/min/1.73
m²
|
Day 0
|
Dialysis
Time Frame: Day 0
|
YES / NO
|
Day 0
|
Presence of macroangiopathic complications
Time Frame: Day 0
|
YES / NO
|
Day 0
|
Presence of obliterative arteritis of the lower limbs
Time Frame: Day 0
|
YES / NO / Don't know
|
Day 0
|
Presence of supra-aortic arterial trunk disease
Time Frame: Day 0
|
YES / NO / Don't know
|
Day 0
|
Presence of coronary artery disease
Time Frame: Day 0
|
YES / NO / Don't know
|
Day 0
|
Oral treatment for diabetes
Time Frame: Day 0
|
Biguanides / Glucose-lowering sulfonamides / Glinides / Dipeptidyl Peptidase-IV / A-glucosidase inhibitors / SGLT2 inhibitors / None
|
Day 0
|
Injectable antidiabetic treatment
Time Frame: Day 0
|
Fast/ultra-fast insulin / Slow/ultra-slow insulin / GLP1 analogues / none
|
Day 0
|
Other treatments
Time Frame: Day 0
|
Yes / No If yes specify: Corticosteroids / Chemotherapy / Immunosuppressors / Immunomodulators / Targeted therapy
|
Day 0
|
Weight
Time Frame: Day 0
|
In kilos
|
Day 0
|
Body Mass Index
Time Frame: Day 0
|
Body Mass Index = kg/m2 where kg is the person's weight in kilograms and m2 is their height in metres squared.
|
Day 0
|
Smoking status
Time Frame: Day 0
|
Yes/ No < 10 cigarettes per day ≥ 10 cigarettes / day Smoking cessation Yes / No |
Day 0
|
Alcohol use
Time Frame: Day 0
|
Yes / No / Withdrawal
|
Day 0
|
Charlson score
Time Frame: Day 0
|
Mild liver disease: Yes / No Moderate to severe liver disease: Yes / No Cerebrovascular disease (excluding hemiplegia): Yes / No Venous insufficiency of the lower limbs: Yes / No Mesenteric vascular disease: Yes / No Renal artery vascular disease: Yes / No Aortic aneurysm : Yes / No Peptic ulcer disease : Yes / No Chronic lung disease : Yes / No Connectivitis: Yes / No Non-metastatic solid tumor : Yes / No Metastatic solid tumor : Yes / No Leukemia : Yes / No Lymphoma, Myeloma: Yes / No AIDS : Yes / No Organ transplant / Yes / No
|
Day 0
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-A02129-34
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Complications
-
Hennepin Healthcare Research InstituteCompletedHyperglycemia | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Complications of Diabetes Mellitus | Diabetes-Related ComplicationsUnited States
-
Royal Prince Alfred Hospital, Sydney, AustraliaMerck Sharp & Dohme LLCCompletedDiabetes Related Complications
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Seoul St. Mary's HospitalUnknownComplications of Diabetes MellitusKorea, Republic of
-
University of AvignonCompletedDiabetes-related ComplicationsFrance
-
Albert Einstein College of MedicineJuvenile Diabetes Research Foundation; National Institutes of Health (NIH)Completed
-
Naestved HospitalUnknown
-
University of Campinas, BrazilConselho Nacional de Desenvolvimento Científico e Tecnológico; ANS PharmaUnknownDiabetes Mellitus, Type 2 | Insulin Resistance | Diabetes-Related ComplicationsBrazil
-
Singapore General HospitalSingapore Eye Research InstituteRecruitingType 2 Diabetes | Diabetes; Neuropathy, Polyneuropathy (Manifestation) | Diabetes Related Complications | Diabetes; Nephropathy (Manifestation) | Diabetes; Retinopathy (Manifestation)Singapore
-
University of AarhusUnknownDiabetes Mellitus, Type 2 | Diabetic Neuropathies | Autonomic Neuropathy | Diabetic Complications Neurological | Polyneuropathy DiabetesDenmark
Clinical Trials on Front view photography of the patient's oral cavity with the help of a smartphone in the diabetology department.
-
OsteovoxUnknownTemporomandibular DisorderBelgium, France, Italy
-
Dokuz Eylul UniversityCompletedMucositis | Pediatric Cancer | Oral CavityTurkey
-
Madigan Army Medical CenterUnknownLow Back Pain | Myofascial Pain Syndrome Lower BackUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain CancerUnited States